drugset / Trial / NCT02792062
A Food Effect Study of TAK-385 Final Formulation
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate food effects on the pharmacokinetics of a single oral dose of TAK-385 in Japanese premenopausal healthy adult women.
Timeline
- Start
- 2016-07-04
- Primary completion
- 2016-08-31
- Completion
- 2016-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Relugolix | Small molecule | 40 mg | Oral |
Indications
No indication recorded.